Supernus Pharmaceuticals, Inc. (SUPN) NASDAQ
49.91
-0.55(-1.09%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
49.91
-0.55(-1.09%)
Currency In USD
| Market Cap | 2.81B |
| Enterprise Value | -95.28B |
| P/E Ratio | -74.24 |
| PEG Ratio | 0.7 |
| Price/Sales Ratio | 4 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | -132.43 |
| Enterprise/EBITDA | -907.18 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.05 |
| Operating Margin | -0.06 |
| Return On Assets | -0 |
| Return On Equity | -0 |
| Revenue | 718.95M |
| Revenue/Share | 12.54 |
| Gross Profit | 644.39M |
| EBITDA | 41M |
| Net Income | -38.55M |
| Diluted EPS | -0.68 |
| Total Cash | 308.67B |
| Total Cash/Share | 5,382.78 |
| Total Debt | 30.37B |
| Total Debt/Equity | 0.03 |
| Current Ratio | 1.9 |
| Book Value Per Share | 18,514.82 |
| 52-Week Change | 60.12 |
| 52-Week High | 59.68 |
| 52-Week Low | 29.16 |
| Moving Average 50 Days | 51.18 |
| Moving Average 200 Days | 44.61 |
| Average Volume | 743,035 |
| Shares Outstanding | 57.58M |
| % Held by Institutions | 101.26 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |